New TB vaccine candidate MTBVAC enters Mid-Stage human trial
⭐️ VACCINE ⭐️
Ongoing
This phase II trial tests a new tuberculosis vaccine called MTBVAC (BBV169) in 164 healthy adolescents and adults. Some participants get the new vaccine, others get the standard BCG vaccine. The study checks how safe the vaccine is and how well it triggers an immune response, aim…
Phase: PHASE2 • Sponsor: Bharat Biotech International Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:25 UTC